Panda Britta, Stiller Robert, Panda Alexander
Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
J Matern Fetal Neonatal Med. 2011 Mar;24(3):402-6. doi: 10.3109/14767058.2010.497882. Epub 2010 Jul 1.
The Center for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) recommend influenza vaccination for all pregnant women during the influenza season. However, the actual rate of vaccination is substantially below the target levels. Given the recent emergence of novel influenza strains, there is an important need to address knowledge gaps in women and their healthcare providers to improve vaccination coverage for pregnant women during inter-pandemic and pandemic periods. This study attempted to identify potentially remediable attitudinal factors among women and their physicians that may present barriers to influenza vaccination and then assess the impact of interventions to increase the influenza vaccination rate in pregnant women.
This prospective study initially analyzed patient and physician knowledge regarding the influenza vaccine in pregnancy and then examined the impact of several interventions aimed to increase immunization rates implemented over the following year. Influenza vaccination rates were assessed before and after the interventions.
Five hundred twenty patients were enrolled in the study during the influenza season 2007/2008. Only 19% of those patients reported receiving the influenza vaccination and only 28% recalled that the vaccine was offered. Following this, in the summer and fall of 2008, we performed a physician education program and distributed posters advertising the influenza vaccine to all offices offering prenatal care in our area in order to increase patient awareness of the need for the vaccine. In the following influenza season, we again reassessed the vaccination rate and patient's knowledge and awareness of the vaccine in 480 postpartum women. Influenza vaccination rates increased from 19% to 31%. After the intervention, 51% of patients recalled that the vaccine was offered to them during the pregnancy as opposed to only 28% the year prior.
Understanding the specific barriers to vaccination that our population faced was helpful in designing the interventions to improve knowledge and acceptance of influenza vaccination in pregnancy, which led to an increased vaccination rates in women.
疾病控制与预防中心(CDC)和美国妇产科医师学会(ACOG)建议所有孕妇在流感季节接种流感疫苗。然而,实际接种率远低于目标水平。鉴于新型流感毒株的近期出现,迫切需要解决女性及其医疗服务提供者在知识方面的差距,以提高大流行间期和大流行期间孕妇的疫苗接种覆盖率。本研究试图确定女性及其医生中可能对流感疫苗接种造成障碍的潜在可纠正态度因素,然后评估旨在提高孕妇流感疫苗接种率的干预措施的影响。
这项前瞻性研究首先分析了患者和医生关于孕期流感疫苗的知识,然后考察了次年实施的旨在提高免疫接种率的几种干预措施的影响。在干预前后评估流感疫苗接种率。
在2007/2008流感季节,520名患者参与了该研究。这些患者中只有19%报告接种了流感疫苗,只有28%记得曾被提供过疫苗。此后,在2008年夏秋季节,我们开展了一项医生教育项目,并向我们地区所有提供产前护理的诊所分发宣传流感疫苗的海报,以提高患者对疫苗需求的认识。在下一个流感季节,我们再次对480名产后妇女的疫苗接种率以及她们对疫苗的知识和认识进行了重新评估。流感疫苗接种率从19%提高到了31%。干预后,51%的患者记得在孕期被提供过疫苗,而前一年只有28%。
了解我们的人群面临的疫苗接种具体障碍有助于设计干预措施,以提高对孕期流感疫苗接种的认识和接受度,从而提高女性的疫苗接种率。